State's Department of Food and Drugs Administration (FDA) today said more than 2 lakh bottles of the cough syrup supplied by a leading pharmaceutical company to a Hisar-based firm - M/s J P Medicose - were found to have been diverted to Bangladesh illegally by the firm in connivance with a fictious Bhiwani-based medicine wholesaler.
State Drug Controller G L Singhal said investigations by the FDA revealed that the huge quantities of the cough syrup were supplied by the pharma company directly to the Hisar- based dealer, who had further shown to have supplied the entire stocks to a Bhiwani-based unlicensed medicine trader, whose licenses had expired in 2008.
He said that on further investigations, it was found that the entire sale was fake as the firm to which sales had been made was non-existent.
FIR under various provisions of Narcotic Drugs and Psychotropic Substances Act, 1985 has been registered against the Hisar-based firm and its owner for illicit transshipment, a statement by state government said today.
The premises of the firm has also been sealed.
Meanwhile, the FDA authorities said investigations into the matter led to another case of 1.5 lakh bottles of the cough syrup being supplied by the pharma company to another Ambala-based medicine trader, M/S Laxmi Drugs Store, who also allegedly syphoned off the entire stocks illicitly and prepared fake documents to have sold to a wholesaler who never purchased any of the product.
Further investigations in to the cases are on.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
